Chinese artificial intelligence (AI) developer Megvii Technology has raised $750 million in Series D funding led by Bank of China Group Investment. It brings the company’s valuation to around $4 billion.
Abu Dhabi Investment Authority, ICBC Asset Management, and Macquarie Group also participated. Megvii is said to be preparing for a $1 billion Hong Kong IPO within the year. The capital will be applied...
Meten International Education Group, a Chinese online-to-offline (O2O) English language training provider that mainly caters to adult students, has filed for a US IPO. DG Capital is the primary PE investor in the company.
VisVires New Protein, a Singapore-based VC firm specializing in food technology, has launched its second fund with a target of $150 million. Fund I closed at $40 million in 2016.
Shanghai-based drug developer Allist Pharmaceuticals has raised RMB1.2 billion ($171 million) in a Series A round of funding led by Shiyu Capital. Other participants include Loyal Valley Capital and Suzhou Industrial Park Bioventure Investment.
SBI Investment, the VC arm of Japan’s SBI Holdings, has joined a JPY3.8 billion $35 million Series B round for Pixie Dust Technologies, a local company developing novel uses for ultrasonic waves.